Literature DB >> 32876887

Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge.

Huan Ma1,2, Dan Zhao2, Weihong Zeng1,2, Yunru Yang2, Xiaowen Hu3, Peigen Zhou4, Jianping Weng1,5,6, Linzhao Cheng7,8, Xueying Zheng9,10,11, Tengchuan Jin12,13,14.   

Abstract

Entities:  

Year:  2020        PMID： 32876887      PMCID： PMC7463100          DOI： 10.1007/s11427-020-1805-0

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   6.038


× No keyword cloud information.
  15 in total

1.  Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Authors:  Henry T Peng; Shawn G Rhind; Andrew Beckett
Journal:  JMIR Public Health Surveill       Date:  2021-04-07

2.  Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients.

Authors:  Lu He; Wanzhou Xu; Cheng Zeng; Ying Li; Ren Lin; Xiaojie Xie; Hongmiao Xia; Shiqi Tang; Lijuan Xu; Changzheng Chen
Journal:  J Infect       Date:  2022-04-21       Impact factor: 38.637

Review 3.  The immunology of SARS-CoV-2 infections and vaccines.

Authors:  Lilit Grigoryan; Bali Pulendran
Journal:  Semin Immunol       Date:  2020-11-17       Impact factor: 11.130

Review 4.  Advances in immunotherapy for COVID-19: A comprehensive review.

Authors:  Masoomeh Masoomikarimi; Behzad Garmabi; Javad Alizadeh; Erfan Kazemi; Amirhossein Azari Jafari; Seyyedmohammadsadeq Mirmoeeni; Motahareh Dargahi; Niloofar Taheri; Reza Jafari
Journal:  Int Immunopharmacol       Date:  2021-01-22       Impact factor: 5.714

Review 5.  Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?

Authors:  Ligong Lu; Hui Zhang; Meixiao Zhan; Jun Jiang; Hua Yin; Danielle J Dauphars; Shi-You Li; Yong Li; You-Wen He
Journal:  Sci China Life Sci       Date:  2020-12-01       Impact factor: 6.038

6.  Potent Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain.

Authors:  Huan Ma; Weihong Zeng; Xiangzhi Meng; Xiaoxue Huang; Yunru Yang; Dan Zhao; Peigen Zhou; Xiaofang Wang; Changcheng Zhao; Yong Sun; Peihui Wang; Huichao Ou; Xiaowen Hu; Yan Xiang; Tengchuan Jin
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

7.  The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose-Study in Healthcare Workers Group in Poland.

Authors:  Joanna Kwiecińska-Piróg; Jana Przekwas; Zuzanna Kraszewska; Alicja Sękowska; Sylwia Brodzka; Natalia Wiktorczyk-Kapischke; Katarzyna Grudlewska-Buda; Ewa Wałecka-Zacharska; Maciej Zacharski; Aneta Mańkowska-Cyl; Eugenia Gospodarek-Komkowska; Krzysztof Skowron
Journal:  Vaccines (Basel)       Date:  2021-11-27

8.  Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI.

Authors:  Fabian Bohländer; Dennis Riehl; Sabrina Weißmüller; Marcus Gutscher; Jörg Schüttrumpf; Stefanie Faust
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

9.  Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects.

Authors:  Elena Criscuolo; Roberta A Diotti; Marta Strollo; Serena Rolla; Alessandro Ambrosi; Massimo Locatelli; Roberto Burioni; Nicasio Mancini; Massimo Clementi; Nicola Clementi
Journal:  J Med Virol       Date:  2020-11-01       Impact factor: 20.693

Review 10.  Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy.

Authors:  Daniele Focosi; Fabrizio Maggi; Paola Mazzetti; Mauro Pistello
Journal:  Rev Med Virol       Date:  2020-09-21       Impact factor: 11.043
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.